Michael S Stalvey

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. doi request reprint A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis
    Michael S Stalvey
    University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Pediatr Pulmonol 47:252-63. 2012
  2. doi request reprint CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes
    Michael S Stalvey
    Department of Pediatrics, University of Florida, College of Medicine, P O Box 100296, Gainesville, FL 32610, USA
    Cytokine 44:154-9. 2008
  3. ncbi request reprint Growth hormone therapy improves growth in children with cystic fibrosis related liver disease
    Michael S Stalvey
    University of Florida, Department of Pediatrics, Division of Pediatric Endocrinology, Gainesville, FL, USA
    J Pediatr Endocrinol Metab 21:793-7. 2008
  4. doi request reprint Endocrine parameters of cystic fibrosis: back to basics
    Michael S Stalvey
    Department of Pediatrics and the Gene Therapy Center, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    J Cell Biochem 108:353-61. 2009
  5. doi request reprint Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation
    Troy D Pashuck
    Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida 32610, USA
    Pediatr Res 65:311-6. 2009
  6. ncbi request reprint Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury
    Michael S Stalvey
    Department of Pathology, University of Florida, College of Medicine, PO Box 100275, Gainesville, FL 32610, USA
    Diabetes 55:1939-45. 2006

Collaborators

Detail Information

Publications6

  1. doi request reprint A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis
    Michael S Stalvey
    University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    Pediatr Pulmonol 47:252-63. 2012
    ..We evaluated safety and efficacy of recombinant human growth hormone (rhGH) for improving growth, lean body mass (LBM), pulmonary function, and exercise tolerance in children with cystic fibrosis (CF) and growth restriction...
  2. doi request reprint CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes
    Michael S Stalvey
    Department of Pediatrics, University of Florida, College of Medicine, P O Box 100296, Gainesville, FL 32610, USA
    Cytokine 44:154-9. 2008
    ..These results suggest that, hyperglycemia may exacerbate the clinical course in CF by impacting immune reactivity. There is clear need to maximize metabolic management in CFRD...
  3. ncbi request reprint Growth hormone therapy improves growth in children with cystic fibrosis related liver disease
    Michael S Stalvey
    University of Florida, Department of Pediatrics, Division of Pediatric Endocrinology, Gainesville, FL, USA
    J Pediatr Endocrinol Metab 21:793-7. 2008
    ..The second patient was a 5 month-old male with advanced liver disease who had transient improved growth and liver function following rhGH. These patients suggest that rhGH is safe and may be effective in children with CFLD...
  4. doi request reprint Endocrine parameters of cystic fibrosis: back to basics
    Michael S Stalvey
    Department of Pediatrics and the Gene Therapy Center, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA
    J Cell Biochem 108:353-61. 2009
    ..In this review, we focus on the known and hypothesized pathogenesis of these two disorders. Additionally, the molecular underpinnings of CF will be explained along with the potential interactions with endocrine disease phenotypes...
  5. doi request reprint Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation
    Troy D Pashuck
    Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, Florida 32610, USA
    Pediatr Res 65:311-6. 2009
    ..This proanabolic observation in male CF mice is consistent with other clinical sex differences in CF...
  6. ncbi request reprint Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury
    Michael S Stalvey
    Department of Pathology, University of Florida, College of Medicine, PO Box 100275, Gainesville, FL 32610, USA
    Diabetes 55:1939-45. 2006
    ..These studies suggest metabolic derangements in CFRD originate from an islet dysfunction inherent to the CFTR(-/-) state...